Related Experiment Video
Updated: Feb 9, 2026

En Face Preparation of Mouse Blood Vessels
Published on: May 19, 2017
Obesity Protects Cancer from Drugs Targeting Blood Vessels
1Department of Microbiology, Tumor, and Cell Biology, Karolinska Institutet, 171 77 Stockholm, Sweden.
Abstract:
Drugs that target angiogenesis are commonly used for treating various cancers, but their clinical benefits are limited. In a recent Science Translational Medicine article, Incio et al. (2018) provide mechanistic insight on the role of obesity in the development of anti-VEGF drug resistance in human patients and murine models of breast cancer.
Insights
Obesity promotes resistance to anti-angiogenic cancer drugs like anti-VEGF therapies. Understanding this link in breast cancer offers new strategies to improve treatment effectiveness for obese patients.
Area of Science:
- Oncology
- Cancer Biology
- Metabolic Syndrome
Background:
- Anti-angiogenic drugs targeting vascular endothelial growth factor (VEGF) are standard cancer treatments.
- Clinical efficacy of these drugs is often limited by the development of resistance.
- The influence of patient metabolic status on drug response is an emerging area of research.
Purpose of the Study:
- To investigate the mechanistic role of obesity in the development of resistance to anti-VEGF therapy.
- To explore potential therapeutic strategies to overcome obesity-induced drug resistance in breast cancer.
Main Methods:
- Utilized human patient data and preclinical murine models of breast cancer.
- Analyzed molecular and cellular mechanisms linking obesity to anti-VEGF drug response.
- Assessed the impact of obesity on tumor angiogenesis and drug efficacy.
Main Results:
- Obesity was identified as a significant factor contributing to acquired resistance to anti-VEGF therapy.
- Specific metabolic pathways associated with obesity were found to drive pro-angiogenic signaling, counteracting drug effects.
- Obese models exhibited reduced sensitivity to anti-VEGF agents compared to non-obese counterparts.
Conclusions:
- Obesity impairs the effectiveness of anti-VEGF cancer drugs by promoting therapeutic resistance.
- Targeting obesity-related metabolic alterations may represent a viable strategy to enhance anti-angiogenic therapy outcomes.
Related Concept Videos
Structure of Blood Vessels
Anatomy of Blood Vessels
Arteries
Arteries circulate oxygenated blood from the heart, except the pulmonary artery, which transports deoxygenated blood to the lungs. Large arteries, such as the aorta,...
Development of Blood Vessels
The initial formation of this system is facilitated by the small amount of yolk present in the ovum and yolk sac. Blood vessels originate from...
Overview of Blood Vessels
Arteries and Arterioles: Arteries are muscular and elastic vessels that primarily carry oxygenated blood from the heart to body tissues, except for the pulmonary artery, which carries deoxygenated blood. They have thick walls to withstand high pressure and contain a layer of muscle tissue, allowing them to expand or contract as...
Drug Dosing: Obese Patients
Pharmacokinetics in Obese Patients: Drug Absorption and Distribution

